24小时热门版块排行榜    

查看: 432  |  回复: 0

liruihan

铁杆木虫 (正式写手)

[交流] Proton Pump Inhibitors but Not H2RAs Linked to Fracture Risk

May 10, 2011 — Proton pump inhibitor (PPI) use is linked to fracture risk, according to the results of a meta-analysis reported in the May/June issue of the Annals of Family Medicine.
"[PPIs] and histamine 2 receptor antagonists (H2RAs) are the most popular [acid-suppressive drugs] available, and millions of individuals currently take these medications on a continuous or long-term basis," write Chun-Sick Eom, MD, MPH, from Seoul National University Hospital, Republic of Korea, and colleagues. "These potent drugs are used to treat various disorders, and indications for long-term maintenance therapy with this drug class continue to expand. The relationship between [acid-suppressive drug] use and bone health remains unclear."

Using common keywords, the reviewers searched MEDLINE (PubMed), EMBASE, and the Cochrane Library databases from their beginnings through December 2010. Selection criteria were case-control, nested case-control, and cohort study designs. The articles were independently reviewed and selected by 2 investigators. Heterogeneity in the included articles necessitated use of random effects meta-analysis to arrive at pooled effect estimates.

The final analyses included 5 case-control studies, 3 nested case-control studies, and 3 cohort studies selected from 1809 articles meeting the initial inclusion criteria. With use vs nonuse of PPIs, the pooled odds ratio (OR) for fracture was 1.29 (95% confidence interval [CI], 1.18 - 1.41) compared with 1.10 (95% CI, 0.99 - 1.23) for use vs nonuse of H2RAs.

Risk for any fracture and for hip fracture was increased with long-term use of PPIs (adjusted OR, 1.30 [95% CI, 1.15 - 1.48]; adjusted OR, 1.34 [95% CI, 1.09 - 1.66], respectively). Vertebral fracture risk was also increased by 54% with PPI use. In contrast, long-term use of H2RA was not significantly associated with fracture risk.

"We found possible evidence linking PPI use to an increased risk of fracture, but no association between H2RA use and fracture risk," the study authors write. "Widespread use of PPIs with the potential risk of fracture is of great importance to public health. Clinicians should carefully consider their decision to prescribe PPIs for patients already having an elevated risk of fracture because of age or other factors."

Limitations of this study include possible uncontrolled confounding. The study authors therefore recommend further prospective studies including large randomized controlled trials with long follow-up.

"It is not necessary to treat patients to the point of an achlorhydric state to resolve acid reflux symptoms, so we recommend that drug doses be chosen thoughtfully with consideration of what is necessary to achieve desired therapeutic goals," the study authors conclude.

In an accompanying editorial, James M. Gill, MD, MPH, from Delaware Valley Outcomes Research in Wilmington, and colleagues discuss balancing risks and benefits of PPIs.

"PPIs have clear benefits in patients that require them, and they should not be denied to patients who are likely to benefit from them," the editorialists write. "On the other hand, long-term PPI exposure may lead to other unwanted effects and should be reserved for patients likely to benefit from them. They should not be used long-term for undifferentiated dyspepsia, but neither should they be denied for patients with established persistent [gastroesophageal reflux disease], [nonsteroidal anti-inflammatory drugs] risk, and hypersecretory states, while aiming for the lowest effective maintenance dose."

A National Research Foundation of Korea Grant funded by the Korean government supported this study. The study authors and editorialists have disclosed no relevant financial relationships.
回复此楼
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
相关版块跳转 我要订阅楼主 liruihan 的主题更新
普通表情 高级回复 (可上传附件)
最具人气热帖推荐 [查看全部] 作者 回/看 最后发表
[考研] 化工专硕348,一志愿985求调剂 +4 弗格个 2026-02-28 6/300 2026-02-28 22:00 by wang_dand
[考研] 292求调剂 +3 yhk_819 2026-02-28 3/150 2026-02-28 21:57 by gaoxiaoniuma
[考研] 304求调剂 +3 52hz~~ 2026-02-28 4/200 2026-02-28 21:41 by gaoxiaoniuma
[考研] 290求调剂 +5 材料专硕调剂; 2026-02-28 6/300 2026-02-28 21:40 by gaoxiaoniuma
[考研] 材料学调剂 +5 提神豆沙包 2026-02-28 5/250 2026-02-28 21:34 by gaoxiaoniuma
[考研] 264求调剂 +3 巴拉巴拉根556 2026-02-28 3/150 2026-02-28 21:31 by gaoxiaoniuma
[考研] 求调剂 +4 repeatt?t 2026-02-28 4/200 2026-02-28 21:16 by gaoxiaoniuma
[考研] 284求调剂 +4 天下熯 2026-02-28 4/200 2026-02-28 21:13 by gaoxiaoniuma
[考研] 276求调剂 +3 路lyh123 2026-02-28 4/200 2026-02-28 19:45 by 路lyh123
[考博] 博士推荐 +5 花儿笑? 2026-02-21 6/300 2026-02-28 18:53 by nxgogo
[考研] 0856材料求调剂 +10 hyf hyf hyf 2026-02-28 11/550 2026-02-28 18:50 by 无际的草原
[教师之家] 版面费该交吗 +15 苹果在哪里 2026-02-22 18/900 2026-02-28 18:20 by mibaomingg
[考研] 材料调剂 +3 爱擦汗的可乐冰 2026-02-28 3/150 2026-02-28 18:06 by houyaoxu
[考博] 博士自荐 +3 kkluvs 2026-02-28 3/150 2026-02-28 16:59 by StarAura
[高分子] 求环氧树脂研发1名 +3 孙xc 2026-02-25 11/550 2026-02-28 16:57 by ichall
[考研] 0856调剂 +3 刘梦微 2026-02-28 3/150 2026-02-28 13:22 by houyaoxu
[考研] 寻找调剂 +3 LYidhsjabdj 2026-02-28 3/150 2026-02-28 12:59 by miniwendy
[硕博家园] 博士自荐 +6 科研狗111 2026-02-26 9/450 2026-02-28 12:32 by seaskyy
[考研] 272求调剂 +3 田智友 2026-02-28 3/150 2026-02-28 12:31 by 王加浩to
[硕博家园] 【博士招生】太原理工大学2026化工博士 +4 N1ce_try 2026-02-24 8/400 2026-02-26 08:40 by N1ce_try
信息提示
请填处理意见